Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare
Submit Your Information
Create a Profile
Get In Touch Mobile
Jeffrey Rommel, MD
Dr. Jeffrey Rommel began his research career at CNS Healthcare as a Psychologist in 2014 bringing a rich history of experience as Adjunct Professor, Therapist and Psychometrician. He developed a passion for research and has been active in over 100 Pediatric, Adolescent, Adult, and Geriatric Ph II – IV clinical trials in Addiction, Pain, Psychiatry, Sleep, Neurology, which contributed to 108 new drugs being brought to market.
Dr. Rommel is an Investigator and rater on many trials – he strictly adheres to placebo response guidelines and has received accolades from Sponsors for the quality of his data. Dr. Rommel is a leader in the exciting research of Psychedelics and is a Certified Psychedelic Therapist/Dosing Session Monitor on Schedule 1 trials.
Articles
Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare
Jim Leary Joins Alcanza as Chief Information Officer
Alcanza Clinical Research Announces Launch of Enspire Clinical Research in Illinois
Ready to be part of healthcare history? Find the right clinical trial for you.
